
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis
Anqi Ge, Qi He, Zhao Da, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 13
Anqi Ge, Qi He, Zhao Da, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 13
Showing 13 citing articles:
Targeting ferroptosis: a new therapeutic opportunity for kidney diseases
Zhiyong Long, Yanfang Luo, Min Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Zhiyong Long, Yanfang Luo, Min Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Ferrostatin‑1 alleviates liver injury via decreasing ferroptosis following ricin toxin poisoning in rat
Ruijiao Lin, Zijie Jia, Hongbing Chen, et al.
Toxicology (2024) Vol. 503, pp. 153767-153767
Open Access | Times Cited: 5
Ruijiao Lin, Zijie Jia, Hongbing Chen, et al.
Toxicology (2024) Vol. 503, pp. 153767-153767
Open Access | Times Cited: 5
Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application
Murshid Imam, Jiale Ji, Zhijie Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Murshid Imam, Jiale Ji, Zhijie Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Identification of PIF1 as a Ferroptosis-Related Prognostic Biomarker Correlated with Immune Infiltration in Hepatocellular Carcinoma
Feng Liu, Ping Yin, Lifang Lu, et al.
Applied Biochemistry and Biotechnology (2025)
Closed Access
Feng Liu, Ping Yin, Lifang Lu, et al.
Applied Biochemistry and Biotechnology (2025)
Closed Access
The marine xanthophyll diatoxanthin as ferroptosis inducer in MDAMB231 breast cancer cells
Clementina Sansone, Luigi Pistelli, Christophe Brunet
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Clementina Sansone, Luigi Pistelli, Christophe Brunet
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
BUB1 Inhibition Induces Ferroptosis in Triple-Negative Breast Cancer Cell Lines
Sushmitha Sriramulu, Shivani Thoidingjam, Stephen L. Brown, et al.
DNA (2025) Vol. 5, Iss. 1, pp. 16-16
Open Access
Sushmitha Sriramulu, Shivani Thoidingjam, Stephen L. Brown, et al.
DNA (2025) Vol. 5, Iss. 1, pp. 16-16
Open Access
CD47 Contributes to the Proliferation of Breast Cancer
Junbin Wang, Xia Wu, Xuejian Liu, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Junbin Wang, Xia Wu, Xuejian Liu, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
F-box/WD Repeat-Containing Protein 5 Promotes Breast Cancer Progression by Regulating Ferroptosis via Enhancing Krüppel-like Factor 13 Ubiquitination Through Phosphoinositide 3-Kinase/Serine/Threonine Protein Kinase Pathway
Chen Chen, Hui Li, Ziyi Zhang, et al.
Rejuvenation Research (2025)
Closed Access
Chen Chen, Hui Li, Ziyi Zhang, et al.
Rejuvenation Research (2025)
Closed Access
Myricetin inhibits 4 T1 breast tumor growth in mice via induction of Nrf-2/GPX4 pathway-mediated Ferroptosis
Xiaomin Niu, Xuhao Ding, Qing Tong, et al.
Toxicology and Applied Pharmacology (2024) Vol. 488, pp. 116990-116990
Closed Access | Times Cited: 2
Xiaomin Niu, Xuhao Ding, Qing Tong, et al.
Toxicology and Applied Pharmacology (2024) Vol. 488, pp. 116990-116990
Closed Access | Times Cited: 2
A new therapeutic strategy for luminal A-breast cancer treatment: vulpinic acid as an anti-neoplastic agent induces ferroptosis and apoptosis mechanisms
Ayşe Hale Alkan, Mine Ensoy, Demet Cansaran‐Duman
Medical Oncology (2024) Vol. 41, Iss. 9
Closed Access | Times Cited: 1
Ayşe Hale Alkan, Mine Ensoy, Demet Cansaran‐Duman
Medical Oncology (2024) Vol. 41, Iss. 9
Closed Access | Times Cited: 1
Brusatol improves the efficacy of sorafenib in Huh7 cells via ferroptosis resistance dependent Nrf2 signaling pathway
Xujin Liu, Tianyi Liu, Zhonghua Zhou, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150762-150762
Closed Access
Xujin Liu, Tianyi Liu, Zhonghua Zhou, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150762-150762
Closed Access
Targeting ferroptosis reveals a new strategy for breast cancer treatment: a bibliometric study
Junlin Liu, Rong Tang, Jie Zheng, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Junlin Liu, Rong Tang, Jie Zheng, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access